Tempus

According to Reuters today, starting from Tuesday local time, Wall Street began to be optimistic about Tempus AI, a genetic testing company supported by SoftBank. The company has an AI-driven clinical and molecular database and is believed to bring more powerful diagnostic and testing tools. Tempus AI is headquartered in Chicago, USA, and sells genomic diagnostic testing products to clinicians and hospital systems, covering oncology, psychiatry, radiology and cardiology. Seven brokerages including JPMorgan Chase, Morgan Stanley, Bank of America Global Research and Stifel gave the first...